A trial in advanced colorectal cancer opens the door to a future blood test to predict the most efficient treatment for reducing metastasis
The study, published in 'Annals of Oncology' aimed to demonstrate that choosing the treatment regime based on genetic variants could improve the prognosis of patients with advanced colorectal cancer. Although this primary objective was not achieved, the trial did show that a blood test can be used to predict the most efficient treatment to reduce metastasis.
